Steroid sensitive nephrotic syndrome is one of the most common pediatric glomerular
diseases. Unfortunately, it follows a relapsing and remitting course in the majority of cases …

The use of corticosteroids in the treatment of steroid-sensitive nephrotic (SSNS) syndrome in
children has evolved surprisingly slowly since the ISKDC consensus over 50 years ago …

Levamisole has been considered the least toxic and least expensive steroid-sparing drug for
preventing relapses of steroid-sensitive idiopathic nephrotic syndrome (SSINS). However …

Both levamisole and mycophenolate mofetil (MMF) prevent relapses in patients with
frequently relapsing nephrotic syndrome; however, their efficacy has not been compared …

Minimal change nephropathy (MCN) is the third most common cause of primary nephrotic
syndrome in adults. Most patients with MCN respond to corticosteroid therapy, but relapse is …

Introduction Idiopathic nephrotic syndrome (INS) is characterised by a high relapse rate up
to 80% after initial response to standard therapy with corticosteroids. Steroid toxicity is …

Results: The duration of nephrotic syndrome was 3.4±2.9 years, and the number of relapses
before levamisole treatment was 6.0±3.4. The dose of prednisone on initiation of levamisole …

Present evidence regarding the efficacy and safety of levamisole in childhood nephrotic
syndrome (NS), particularly the steroid-sensitive NS (SSNS), is limited. We searched …

Objectives: To determine the effectiveness of levamisole in maintaining remission of
proteinuria in children with frequent relapsing and steroid dependent nephrotic syndrome …

Background Majority of children with nephrotic syndrome are steroid sensitive, but treatment
of difficult to treat nephrotic (frequent relapsing, steroid dependent and steroid resistant) …